Cidara Therapeutics, Inc.

BRIDGEWAY CAPITAL MANAGEMENT, LLC

Report date

3/31/2024

Quarter

2024 Q1

Filed

5/15/2024

Shares

60,060

Value ($000)

55

Weight

0.0%

2019 Q4 - 2024 Q1 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q1	5/15/2024	55	0.0%	60,060	3/31/2024
2023 Q4	2/14/2024	48	0.0%	60,060	12/31/2023
2023 Q3	11/14/2023	57	0.0%	60,060	9/30/2023
2023 Q2	8/14/2023	68	0.0%	60,060	6/30/2023
2022 Q3	11/14/2022	88	0.0%	140,000	9/30/2022
2022 Q2	8/15/2022	117	0.0%	240,000	6/30/2022
2022 Q1	5/16/2022	208	0.0%	250,000	3/31/2022
2021 Q4	2/14/2022	441	0.0%	347,200	12/31/2021
2021 Q3	11/15/2021	266	0.0%	118,878	9/30/2021
2021 Q2	8/16/2021	240	0.0%	118,878	6/30/2021
2021 Q1	5/17/2021	436	0.0%	163,878	3/31/2021
2020 Q4	2/16/2021	568	0.0%	283,860	12/31/2020
2020 Q3	11/16/2020	504	0.0%	177,004	9/30/2020
2020 Q2	8/31/2020	653	0.0%	177,004	6/30/2020
2020 Q1	5/15/2020	315	0.0%	127,004	3/31/2020
2019 Q4	2/14/2020	397	0.0%	103,282	12/31/2019